nivolumab
bms
['nivo', 'nivolumab', 'renal,(-adrenal)']
first phase iii neoadjuvant io trial in renal cell carcinoma with nivolumab showing no difference in rfs #esmo22 
Professor of Urology, Chairman Department of Urology, EiC "Aktuelle Urologie", Editor World Journal of Urology. Chairman ESUP, EAU-Board Member